PGEN
Precigen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.10
−0.56%Leverage
- Debt / equity
- 2.26x
- Net debt / equity
- 1.88x
- Debt / assets
- 0.58x
- Debt / EBITDA
- -0.68x
- Net debt / EBITDA
- -0.57x
Liquidity & coverage
- Current ratio
- 4.58x
- Quick ratio
- 3.89x
- Cash ratio
- 1.30x
- Interest coverage
- -4.06x
- EBITDA / interest
- -14.90x
- Working capital
- $105.0M
Cash & dividend
- FCF / debt
- -1.18x
- Cash flow / debt
- -1.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026